1. Home
  2. CYTK vs MKSI Comparison

CYTK vs MKSI Comparison

Compare CYTK & MKSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTK
  • MKSI
  • Stock Information
  • Founded
  • CYTK 1997
  • MKSI 1961
  • Country
  • CYTK United States
  • MKSI United States
  • Employees
  • CYTK N/A
  • MKSI N/A
  • Industry
  • CYTK Biotechnology: Pharmaceutical Preparations
  • MKSI Industrial Machinery/Components
  • Sector
  • CYTK Health Care
  • MKSI Industrials
  • Exchange
  • CYTK Nasdaq
  • MKSI Nasdaq
  • Market Cap
  • CYTK 5.6B
  • MKSI 5.0B
  • IPO Year
  • CYTK 2004
  • MKSI 1999
  • Fundamental
  • Price
  • CYTK $32.00
  • MKSI $86.14
  • Analyst Decision
  • CYTK Buy
  • MKSI Buy
  • Analyst Count
  • CYTK 15
  • MKSI 12
  • Target Price
  • CYTK $73.71
  • MKSI $135.75
  • AVG Volume (30 Days)
  • CYTK 2.0M
  • MKSI 1.1M
  • Earning Date
  • CYTK 05-06-2025
  • MKSI 05-07-2025
  • Dividend Yield
  • CYTK N/A
  • MKSI 1.02%
  • EPS Growth
  • CYTK N/A
  • MKSI N/A
  • EPS
  • CYTK N/A
  • MKSI 3.36
  • Revenue
  • CYTK $19,218,000.00
  • MKSI $3,654,000,000.00
  • Revenue This Year
  • CYTK $24.01
  • MKSI $7.00
  • Revenue Next Year
  • CYTK $698.33
  • MKSI $6.70
  • P/E Ratio
  • CYTK N/A
  • MKSI $25.67
  • Revenue Growth
  • CYTK 412.21
  • MKSI N/A
  • 52 Week Low
  • CYTK $29.31
  • MKSI $54.84
  • 52 Week High
  • CYTK $61.38
  • MKSI $147.40
  • Technical
  • Relative Strength Index (RSI)
  • CYTK 44.20
  • MKSI 55.46
  • Support Level
  • CYTK $30.02
  • MKSI $80.22
  • Resistance Level
  • CYTK $31.27
  • MKSI $87.91
  • Average True Range (ATR)
  • CYTK 1.32
  • MKSI 3.01
  • MACD
  • CYTK 0.38
  • MKSI -0.67
  • Stochastic Oscillator
  • CYTK 72.12
  • MKSI 41.37

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About MKSI MKS Instruments Inc.

MKS Instruments Inc is engaged in providing instruments, subsystems, and process control systems used to measure, monitor, deliver, and control parameters of manufacturing processes. The company's product portfolio includes instruments, components, and systems required in manufacturing products such as flat panel displays, medical devices, and electronic materials, among others used in industrial technologies, semiconductors, life and health sciences, and research and defense markets. The company organizes itself into three reportable business segments: Vacuum Solutions, Photonics Solutions, and Materials Solutions. The Vacuum Solutions segment contributes the majority of the company's revenue.

Share on Social Networks: